Header Logo

Vu Hoang Tran

Concepts (120)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
5
2018
253
1.970
 Why?
Myocardial Infarction
5
2022
912
1.390
 Why?
Anxiety Disorders
2
2018
192
1.050
 Why?
Tachycardia, Ventricular
2
2018
129
1.030
 Why?
Patient Discharge
2
2018
508
0.880
 Why?
ST Elevation Myocardial Infarction
3
2022
90
0.850
 Why?
Non-ST Elevated Myocardial Infarction
2
2018
32
0.740
 Why?
Circulating Tumor DNA
4
2025
9
0.710
 Why?
Nutrition Surveys
2
2017
142
0.640
 Why?
Percutaneous Coronary Intervention
1
2022
208
0.610
 Why?
Early Detection of Cancer
4
2025
315
0.580
 Why?
Hyperglycemia
1
2018
104
0.560
 Why?
Ventricular Fibrillation
1
2018
106
0.560
 Why?
Deficiency Diseases
1
2017
13
0.550
 Why?
Iodine
1
2017
19
0.550
 Why?
Arrhythmias, Cardiac
1
2018
152
0.550
 Why?
Patient Admission
1
2018
191
0.530
 Why?
Cardiovascular Agents
1
2017
103
0.510
 Why?
Drug Utilization
1
2017
208
0.500
 Why?
Depressive Disorder
1
2018
284
0.500
 Why?
Hospital Mortality
2
2022
867
0.470
 Why?
Length of Stay
1
2017
806
0.430
 Why?
Aged
13
2025
14288
0.430
 Why?
Coronary Artery Disease
1
2017
309
0.420
 Why?
Middle Aged
12
2025
17424
0.410
 Why?
Healthcare Disparities
1
2017
354
0.410
 Why?
Risk Factors
7
2018
5313
0.390
 Why?
Female
16
2025
32611
0.370
 Why?
Male
14
2025
29618
0.370
 Why?
Incidence
4
2018
1373
0.360
 Why?
Biomarkers, Tumor
5
2025
503
0.350
 Why?
Prognosis
4
2018
1735
0.340
 Why?
Atrial Fibrillation
2
2018
837
0.340
 Why?
Massachusetts
5
2018
2061
0.340
 Why?
Humans
23
2025
62963
0.310
 Why?
Cell-Free Nucleic Acids
2
2025
14
0.300
 Why?
Prospective Studies
5
2025
3263
0.260
 Why?
Time Factors
3
2018
3750
0.260
 Why?
DNA Methylation
2
2025
293
0.250
 Why?
Neoplasms
3
2025
1351
0.240
 Why?
Logistic Models
2
2018
1269
0.220
 Why?
Aged, 80 and over
3
2018
5416
0.220
 Why?
Patient Readmission
2
2018
429
0.210
 Why?
Pseudomonas Infections
1
2023
54
0.210
 Why?
Liver Neoplasms
2
2023
297
0.210
 Why?
Prevalence
2
2017
1365
0.200
 Why?
Biomarkers
2
2018
1388
0.190
 Why?
Exome
1
2021
77
0.180
 Why?
Carcinoma, Hepatocellular
1
2023
178
0.180
 Why?
Risk Assessment
2
2018
2053
0.170
 Why?
Pneumonia
1
2023
289
0.170
 Why?
Gene Frequency
1
2020
124
0.170
 Why?
United States
3
2018
7762
0.170
 Why?
Coronary Artery Bypass
1
2022
297
0.170
 Why?
Cardiac Catheterization
1
2022
281
0.170
 Why?
Cardiovascular Diseases
2
2018
833
0.170
 Why?
Genetic Testing
1
2020
133
0.160
 Why?
Alleles
1
2020
449
0.150
 Why?
Mutation
2
2025
2607
0.150
 Why?
Theranostic Nanomedicine
1
2018
8
0.150
 Why?
Radiation-Sensitizing Agents
1
2018
14
0.150
 Why?
Odds Ratio
2
2018
767
0.150
 Why?
Genotype
1
2020
664
0.150
 Why?
Leukocyte Count
1
2018
96
0.150
 Why?
Vietnam
3
2025
173
0.140
 Why?
Gadolinium
1
2018
106
0.140
 Why?
Hospitalization
2
2022
1348
0.140
 Why?
Protective Factors
1
2017
33
0.140
 Why?
Mortality
1
2018
160
0.140
 Why?
Herpes Zoster
1
2017
24
0.140
 Why?
Cerebrovascular Disorders
1
2017
81
0.130
 Why?
Chi-Square Distribution
1
2017
416
0.130
 Why?
Breast Neoplasms
1
2025
1195
0.130
 Why?
Linear Models
1
2017
408
0.130
 Why?
Cohort Studies
2
2021
2549
0.120
 Why?
Blood Glucose
1
2018
483
0.120
 Why?
Survival Rate
1
2018
846
0.120
 Why?
Medication Adherence
1
2017
195
0.120
 Why?
Follow-Up Studies
2
2018
2446
0.120
 Why?
Multivariate Analysis
1
2017
934
0.120
 Why?
Disease Progression
1
2018
1161
0.110
 Why?
Anticoagulants
1
2018
494
0.110
 Why?
Stroke
3
2018
1190
0.110
 Why?
Adult
5
2025
16676
0.110
 Why?
Registries
1
2017
882
0.100
 Why?
Health Services Accessibility
1
2018
555
0.100
 Why?
Nanoparticles
1
2018
518
0.100
 Why?
Depression
1
2018
888
0.090
 Why?
Quality of Life
1
2018
1217
0.090
 Why?
Treatment Outcome
2
2018
5612
0.090
 Why?
Retrospective Studies
2
2025
6563
0.080
 Why?
Cross-Sectional Studies
1
2017
2560
0.080
 Why?
Tobramycin
1
2023
7
0.050
 Why?
DNA, Neoplasm
1
2023
58
0.050
 Why?
Rabbits
1
2023
332
0.050
 Why?
Pseudomonas aeruginosa
1
2023
108
0.050
 Why?
Microbial Sensitivity Tests
1
2023
203
0.050
 Why?
Shock, Cardiogenic
1
2022
101
0.040
 Why?
Hospitals
1
2022
393
0.040
 Why?
Genome-Wide Association Study
1
2020
359
0.040
 Why?
Publication Bias
1
2018
20
0.040
 Why?
Georgia
1
2018
87
0.040
 Why?
Sex Distribution
1
2018
253
0.040
 Why?
Age Distribution
1
2018
259
0.040
 Why?
Polymorphism, Single Nucleotide
1
2020
491
0.040
 Why?
Herpes Zoster Ophthalmicus
1
2017
6
0.040
 Why?
Anti-Bacterial Agents
1
2023
787
0.030
 Why?
Forecasting
1
2018
231
0.030
 Why?
Head and Neck Neoplasms
1
2018
166
0.030
 Why?
Administration, Oral
1
2018
368
0.030
 Why?
Phenotype
1
2020
1196
0.030
 Why?
Venous Thromboembolism
1
2018
148
0.030
 Why?
Brain Neoplasms
1
2018
308
0.030
 Why?
Comorbidity
1
2018
1117
0.030
 Why?
Melanoma
1
2018
331
0.030
 Why?
Randomized Controlled Trials as Topic
1
2018
732
0.030
 Why?
Pregnancy
1
2020
2321
0.030
 Why?
Animals
2
2023
20659
0.030
 Why?
Surveys and Questionnaires
1
2018
2657
0.020
 Why?
Mice
1
2018
10847
0.010
 Why?
Tran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (120)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_